GlaxoSmithKline logo

Patient group funding

European Multiple Sclerosis Platform (EMSP)

EMSP’s goal is to exchange and disseminate information relating to multiple sclerosis considering all issues relevant to people affected by MS .

We have supported this organisation since 2004.

During 2010:

  • We gave an unrestricted grant of €25,000 to help with their activities.

Our support represents 3.67% of their overall income.



During 2009:

  • We gave an unrestricted grant of €25,000 to help them with their activities. 

Our support represents 2.9% of their overall income.



During 2008:

  • We gave an unrestricted grant of €25,000 to help them with their activities.
  • In addition we also gave an honorarium of €500 to support the attendance of the Secretary General at GSK’s European Health Advisory Board meetings.  

Our support represents around 3.4% of their income in 2008



During 2007:

  • We gave an unrestricted grant of €25,000 to help them with their activities. 

Our funding represents 4.4% of their income overall.



During 2006:

  • We gave an unrestricted grant of €25,000 to help EMSP with their activities

Our funding represents 5.9% of their income overall.